Stocktoria
Scholar Rock Holding Corp SRRK
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2018-05-24
Scholar Rock Holding Corp statistics & valuation
Market cap$6.6B
P / B26.7×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | — | — | — | -404.8% | -690.5% |
| Net margin | — | — | — | -405.2% | -700.5% |
| FCF margin | — | — | — | -403.0% | -701.7% |
| Return on assets | -93.5% | -51.9% | -53.3% | -37.6% | -43.3% |
| Return on equity | -154.0% | -66.8% | -73.6% | -51.7% | -76.6% |
| Debt / equity | 0.41× | 0.14× | 0.23× | 0.20× | 0.30× |
| Current ratio | 6.95 | 9.61 | 8.80 | 9.01 | 4.13 |
| Revenue growth | — | — | — | 76.4% | 22.2% |
Source: SEC EDGAR filings · CIK 0001727196 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.